Silver Book Fact

An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay tumor growth. Patients lived a median of 3.7 months before their tumors got worse–as opposed to 1.9 months.

Szabo, Liz. New Weapons Do Battle with Kidney Cancer. USA Today. June 4 2006. http://www.usatoday.com/news/health/2006-06-04-kidney-cancer_x.htm?csp=34

Reference

Title
New Weapons Do Battle with Kidney Cancer
Publication
USA Today
Publication Date
June 4 2006
Authors
Szabo, Liz
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • 5-Year Relative Survival Rates for Cancers in U.S.  
  • Since Congress passed the National Cancer Act in 1971, the percentage of the U.S. population living with, through, or beyond a cancer diagnosis has more than tripled.  
  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.